Trial Profile
A retrospective study to evaluate the effects of infliximab in patients with rheumatoid arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 01 Sep 2015 New trial record